Clinical Trial Update: Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing My-Rept Tablet vs. My-Rept Capsule, each in combination with tacrolimus, in kidney transplant patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• MY-REPT Capsule (MY-REPT)
• My-Rept Tablet
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED